Form 4 for LUNG Pulmonx Corp
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01 | LUNG | Sung Derrick | CFO | S - Sale | $11.03 | -1,264 | 261.5K | -0.5% | -$13.9K |
| D | 2023-03-03 | 2023-03-01 | LUNG | Sung Derrick | CFO | A - Grant | $0.00 | +138.0K | 399.5K | +53% | $0 |
| D | 2023-03-03 | 2023-03-01 | LUNG | Sung Derrick | CFO | A - Grant | $0.00 | +94.5K | 94.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | S | D | 458 | $11.03 | 262,288 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | A | A | 138,000 | $0.00 | 399,482 | D | — | — | (F3) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023. |
| 3 | Common | Common Stock | 2023-03-01 | S | D | 806 | $11.03 | 261,482 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | A | A | 94,500 | $0.00 | 94,500 | D | $11.48 · — to 2033-02-28 | 94,500 Common Stock | (F4) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023. |